We aimed to assess the relationship between neutrophil to lymphocyte ratio (N/L ratio) and functional capacity (FC) of patients with compensated heart failure (CHF).
H eart failure (HF) is an inflammatory neuroendocrine syndrome with negative effects on functional capacity (FC) and quality-of-life, and which causes increased morbidity and mortality. [1, 2] Immunological and inflammatory responses appear to be involved in the development and advancement of chronic HF. [3] The neutrophil/lymphocyte ratio (N/L ratio) is one of several inflammatory parameters that have been proposed as prognostic markers to determine the systemic inflammatory response. The N/L ratio, which is calculated from a complete blood count with differential, is an inexpensive and easy to obtain a marker of inflammation that can aid in the risk stratification of patients with various cardiovascular diseases alongside traditionally used markers. [4] A high N/L ratio is said to be associated with an increased risk of morbidity and mortality in patients with acute decompensated HF. [5] However, its role in the risk stratification of patients with compensated heart failure (CHF) has not been described. In addition, no data exist regarding the association between N/L ratio and FC.
In the present study, we investigated the relationship between N/L ratio and markers of a poor prognosis for patients with HF, including the FC, N-terminal pro-brain natriuretic peptide (NT-proBNP) level, pulmonary artery pressure (PAP), ratio of the early to late ventricular filling velocities (E/Ea ratio), and left atrial (LA) diameter in CHF patients exhibiting left ventricular (LV) systolic dysfunction (LVSD).
PATIENTS AND METHODS

Study population
Patients with chronic HF referred to our department for echocardiographic examination between February and July 2013 and who met the entry criteria for the study were invited to participate. We prospectively studied 94 consecutive HF patients with diagnosed at least 2 years with LVSD secondary to ischemic (n=55) or idiopathic dilated cardiomyopathy (n=39). Ageand gender-matched 70 healthy subjects who had normal echocardiographic findings with using acetylsalicylic acid for the primary prevention of cardiovascular events were enrolled to the study as a control group. On the same day, peripheral venous blood samples were drawn before echocardiography examination and treadmill test in all study population. All patients were screened; the study cohort consisted of patients who fulfilled the following criteria: (1) symptomatic HF associated with systolic d y s f u n c t i o n on echocardiographic examination (ejection fraction [EF] <45%). (2) Optimized oral therapy for the treatment of HF, including the use of acetylsalicylic acid (100-300 mg), angiotensin-converting enzyme-inhibitors or angiotensin receptor antagonists, beta-blockers. Exclusion criteria were as follows: hypoalbuminemia, malignancy, rheumatic valve disease, constrictive pericarditis, hypothyroidism, renal dysfunction (serum creatinine >1.5 mg/dl with or without hemodialysis treatment), cirrhotic liver disease; immunologic or inflammatory disease, hematological diseases, sepsis, active local or systemic infections, a history of recent infection and/ or fever on the last month, anemia, history of blood transfusion on the last 3 months and use of steroidal or non-steroidal anti-inflammatory drugs on the last a month. In addition, patients with decompensated HF who had one of the following criteria were excluded from the study: LVSD with bilateral inspiratory rales, edema, findings on the chest X-ray including pulmonary venous congestion and/or pleural effusions. The investigation conforms with the principles outlined in the declaration of Helsinki. This study was approved by the institutional committee, and informed consent was obtained from all patients before participation.
Transthoracic echocardiography
A comprehensive echocardiographic examination was performed in all subjects by using a Vivid E9 echocardiography machine (GE Vingmed Ultrasound AS, Horten, Norway). The LV and LA diameters were measured from the-apical four chamber view. LV EF was estimated from apical four-and two-chamber views using Simpson's biplane method. [6, 7] Mitral inflow was evaluated at pulsed Doppler analysis. Pulsed-wave Tissue Doppler imaging were used to assess early myocardial relaxation velocity (Ea), plac- ing the sample volume in the ventricular myocardium immediately adjacent to the lateral mitral annulus.
Mitral inflow E-wave and Ea were then used to calculate E/Ea ratio, which was used as an indicator of LV filling pressure. [8] Functional capacity (FC)
Various methods have been proposed to determine the functional status of HF patients. NYHA classification is the most widely used method. [9] In our study, the treadmill exercise test was used because of the subjective nature of the NYHA classification. The best objective method to determine FC is the peak O 2 consumption measured by cardiopulmonary exercise test. [10] However, the cardiopulmonary exercise test is not always available and requires expertise. Instead of it, exercise capacity is usually measured indirectly and expressed as metabolic equivalent (MET). [11] FC status of CHF patients was assessed undergoing symptom-limited treadmill test based on modified Bruce protocol by physicians blinded to the patients' echocardiographic results. Poor FC was defined as achievement of <5 MET in the exercise test.
Laboratory measurements
Peripheral venous blood samples were drawn before echocardiography examination and treadmill test in all study population. Venous blood samples were collected in a tube containing K3 EDTA for measurement of hematologic indices in all patients. Hematologic indices were evaluated from complete blood count analysis performed using the XT-2000i (Sysmex Corporation of America, Long Grove, Illinois, USA) analyzer. NT-proBNP measurement was performed using an electrochemiluminescence sandwich immunoassay (ECLIA, Roche Diagnostics) on a Modular analytics Hitachi Cobas 6000. The N/L ratio was calculated by dividing neutrophil count to lymphocyte count. Afterwards, patients with CHF were divided into two groups with respect to the top and bottom 3 of the N/L ratio. 
RESULTS
The baseline characteristics, NT-proBNP levels, and functional capacities of the patients with CHF are presented in Table 1 3 ; p=0.245). Therefore, the N/L ratio tertile was found to be significantly higher in patients with atrial fibrillation than in those with a normal sinus rhythm (3.67±1.12 × 10 3 vs. 2.79±1.29 × 10 3 ; p=0.029). The patients with CHF were divided into two groups with respect to the top and bottom three N/L ratios. A comparison of patients with an N/L ratio >3 with those having an N/L ratio <3 in terms of poor prognostic markers of HF is shown in Table 3 . The FC levels (3.2±2.05 MET vs. 6.1±2.04 MET; p<0.001) were lower in those CHF patients with an N/L ratio ≥3 than in those with an N/L ratio <3 (Fig. 1) . A correlation analysis between the FC levels and several variables of the CHF patients revealed a significant relationship between FC and N/L ratio (r=−0.612, p<0.001) (Table 4 ). Afterwards, the CHF patients were divided into two groups; low (<5 MET, n = 39) and high (>5 MET, n=55) FC, according to their functional status in an exercise test. Among the variables for which the p<0.25 in the univariate analysis including the smoking, atrial fibrillation, mitral and tricuspid regurgitation, log-NT-proBNP, N/L ratio, LV endsystolic diameter, mean platelet volume (MPV), LV EF, systolic PAP, LA diameter, E/Ea ratio, body mass index, hemoglobin values were included multivariate regression analysis and the N/L ratio and log-NTproBNP were identified to be predictors of patients 
DISCUSSION
In the current study, the lymphocyte count was found to be significantly lower despite a normal neutrophil count, and the N/L ratio was found to be significant- (Fig. 2) . cardiac function, peripheral vascular function, and exercise performance via a number of mechanisms, including the production of oxygen free radicals and apoptosis. [16] [17] [18] [19] Previous studies have demonstrated the lack of a relationship between exercise capacity and conventional echocardiographic parameters such as LV function, and LV diameter. [20] [21] [22] [23] [24] [25] Similarly, we found that FC was poorly correlated with echocardiographic parameters. In contrast, a strong correlation was found between N/L ratio and FC; moreover, N/L ratio was identified as an independent determinant of exercise capacity. We also found that the cut-off value of 2.74 for N/L ratio was a predictor of a poor FC in HF patients (≤5 MET). According these findings, we conclude that the N/L ratio is an inexpensive and easy to obtain a marker that can be used to procure preliminary information about exercise performance in CHF patients.
In the current study, the MPV was increased significantly in the HF group. The MPV, a marker of platelet activity, is increased in patients with acute myocardial infarction and stroke, and it has been shown to be a predictive marker for future adverse coronary events following myocardial infarction. [26, 27] A poorly contracting ventricle allows blood stasis, which can lead to thrombus formation. Previously, Tekin et al. [28] reported that the MPV was significantly greater in patients with DCMP than in normal subjects and that it was strongly associated with LV thrombus formation in these patients. In our study, the MPV was significantly higher in HF patients with an N/L ratio >3 than in those with an N/L ratio <3 and in the control subjects. These results indicate that the thrombogenicity may be increased in patients with an N/L ratio >3. However, further study is needed to determine whether the N/L ratio contributes to LV thrombus formation.
Study limitations
The major limitation of the present study was the relatively small number of patients; subjects were only selected from patients with CHF. Furthermore, the cross-sectional design limited our ability to determine the significance of changes in the N/L ratio for the long-term prognosis and mortality of patients with LVSD. Therefore, other inflammatory parameters such as IL-6, tumor necrosis factor-α and high sensitive C-reactive protein were not measured simultaneously because they are mostly not available in daily practice. ly higher in patients with CHF than in normal subjects. Lymphocytopenia and increased mortality are independently associated in patients with acute and chronic HF. [12] Reduced lymphocyte proliferation and differentiation, neurohumoral activation, and lymphocyte apoptosis are possible mechanisms of lymphocytopaenia. [12] Relative lymphopenia is evidence of the cortisol-induced stress response in patients with cardiovascular disease. [13] The N/L ratio has been proposed as a prognostic marker of the systemic inflammatory response. It is a new addition to the long list of such inflammatory markers. A high N/L ratio is associated with a poor clinical outcome in various cardiac diseases, including acute coronary syndrome, non-ST-segment elevation myocardial infarction (STEMI), and STEMI. [13] [14] [15] Tamhane et al. [13] reported that patients with non-STE-MI or STEMI in tertile 3 had higher in-hospital and 6 months mortality rates. Additionally, a search of the literature revealed only one study of the association between N/L ratio and a poor prognosis in patients with decompensated HF. In that study, Uthamalingam et al. [5] reported that an increase in N/L ratio was associated with increased mortality and morbidity in these patients. Additionally, they found that patients with decompensated HF in tertile 4 had higher morbidity and mortality rates. However, to date, the N/L ratio has not been investigated in patients with CHF. In our study, markers of a poor prognosis in CHF, including FC, NT-proBNP level, E/Ea ratio, PAP, LA diameter, and a EF were found to be significantly higher in those patients with an N/L ratio >3. According to these results, the N/L ratio may be used as an inexpensive marker to aid in the risk stratification of patients with CHF.
Exercise performance is an important parameter since a lower FC translates into independence in daily activities and an improved quality-of-life. Besides, it is an independent predictor of morbidity and mortality in HF patients. Immunological and inflammatory responses are major pathophysiological features in the exercise performance of HF patients. [16] Leukocyte activation and the migration of these cells from the blood to sites of inflammation may play a significant role in reduced exercise capacity. [16, 17] Therefore, recent investigations have suggested that proinflammatory cytokines (e.g., tumor necrosis factor-alpha and interleukin-1 [IL-1]) are capable of modulating
